ALLMedicine™ Primary Pulmonary Hypertension Center

Aug 10th, 2020 - To investigate the microvascular and neural changes in primary pulmonary hypertension (PPH) patients compared with healthy controls. Forty-four eyes of 22 PPH patients were included in this observational clinical cohort study, while forty-four eye...

May 31st, 2020 - Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the...

Apr 6th, 2020 - Primary pulmonary hypertension can lead to hypertrophy of the right ventricle and ultimately to its insufficiency. Lung transplantation remains the only viable treatment for patients with certain forms of this disease. Usage of extracorporeal memb...

Mar 29th, 2020 - Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in ...

Mar 29th, 2020 - This study analyses the data of patients undergoing Combined heart and lung transplant(CHLTx) with primary pulmonary hypertension(PPH),advanced lung diseases with right ventricular failure and uncorrected congenital heart diseases which are not un...

Aug 10th, 2020 - To investigate the microvascular and neural changes in primary pulmonary hypertension (PPH) patients compared with healthy controls. Forty-four eyes of 22 PPH patients were included in this observational clinical cohort study, while forty-four eye...

May 31st, 2020 - Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the...

Apr 6th, 2020 - Primary pulmonary hypertension can lead to hypertrophy of the right ventricle and ultimately to its insufficiency. Lung transplantation remains the only viable treatment for patients with certain forms of this disease. Usage of extracorporeal memb...

Mar 29th, 2020 - Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in ...

Mar 29th, 2020 - This study analyses the data of patients undergoing Combined heart and lung transplant(CHLTx) with primary pulmonary hypertension(PPH),advanced lung diseases with right ventricular failure and uncorrected congenital heart diseases which are not un...

May 19th, 2014 - Endothelin inhibitors Endothelin inhibitors also may play a role in vascular protection. Endothelin is secreted in scleroderma and is a potent vasoconstrictor.

ABSTRACT Pulmonary arterial hypertension (PAH) refers to a group of diseases characterized by high pulmonary artery pressure of unknown mechanism. Primary pulmonary hypertension (PPH) is the idiopathic subset of PAH that affects a mostly young pop.

ORLANDO — Echocardiography overestimates the true prevalence of primary pulmonary hypertension in hemodialysis patients with end-stage renal disease, according to a study presented at a meeting sponsored by the National Kidney Foundation. For this.